Filter
597
Filtered Results: 597
Text search:
pharmacovigilance
Featured
Recommendations
63
New Publications
163
Language
Document type
No document type
268
Guidelines
123
Studies & Reports
85
Strategic & Response Plan
41
Manuals
35
Fact sheets
17
Training Material
9
Resource Platforms
8
Situation Updates
4
Online Courses
4
Infographics
2
Videos
1
Countries / Regions
Kenya
26
Global
19
Ghana
18
Congo, Democratic Republic of
18
South Africa
17
India
17
Uganda
16
Nigeria
15
Western and Central Europe
14
Namibia
13
Rwanda
12
Senegal
12
Eastern Europe
12
Ethiopia
12
Nepal
10
Latin America and the Carribbean
10
West and Central Africa
9
Zambia
9
Sierra Leone
8
Burkina Faso
8
Malawi
8
Tanzania
8
East and Southern Africa
8
Madagascar
8
Africa
7
Benin
6
Haiti
6
South–East Asia Region
6
Philippines
5
Cambodia
5
Bangladesh
5
Russia
5
Botswana
5
Liberia
5
Middle East and North Africa
4
Ukraine
3
Lesotho
3
Cameroon
3
Zimbabwe
3
Mozambique
3
Eastern Europe and Central Asia
3
Chile
2
Syria
2
Burundi
2
Morocco
2
Guinea
2
Asia
2
Paraguay
2
Lebanon
2
Brazil
2
Sudan
2
Mali
2
Chad
2
Libya
2
Indonesia
2
Myanmar / Burma
2
Eswatini/ Swaziland
2
Pakistan
2
Thailand
1
Gambia
1
Togo
1
Laos
1
Afghanistan
1
Jordan
1
Western Pacific Region
1
France
1
Maldives
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Argentina
1
Vietnam
1
Sri Lanka
1
Yemen
1
Georgia
1
Central African Republic
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
300
Clinical Guidelines
59
Public Health
15
Pharmacy & Technologies
11
Capacity Building
9
Women & Child Health
8
Key Resources
7
Toolboxes
Pharmacy
72
COVID-19
62
TB
55
AMR
47
Malaria
41
NTDs
27
HIV
24
Rapid Response
6
Ebola & Marburg
6
Caregiver
5
Planetary Health
5
NCDs
4
Refugee
3
Specific Hazards
2
Global Health Education
2
Cholera
1
Conflict
1
Zika
1
Polio
1
Apart from implementation of TB infection Prevention and Control measures, treatment of those with active TB of the lungs is key in preventing the spread of the TB bacilli. The Public Health Act CAP 242, section 17 classify TB as notifiable infectious disease and under section 26 as part of preventi...
Member States have requested WHO policy guidance on how to facilitate the implementation of national AMS activities in an integrated and programmatic approach. This policy guidance responds to that demand from Member States and is anchored in public health guiding principles in the human health sect...
How to address the global crisis in antibiotic research and development.
The report includes a comprehensive summary and critical evaluation of recent initiatives to overcome the barriers to achieve sustainable access to antibiotics. As antibiotic resistance will continue to develop as long as we ...
The overall goal of the programme, to reduce the malaria morbidity and mortality by 75% (using 2012 as baseline) by the year 2020, continued to be pursued in 2014. The following areas were identified as some of the priorities for the year: Malaria Case Management under which we have Malaria in Pregn...
Policy brief. July 2020
The Federal Ministry of Health (FMOH) has been coordinating sector wide reforms that aim to improve equity and quality of health services. It is widely known that; the sector is growing in line the overall growth and transformation plan of the country and the sector is bein...
В дорожной карте по борьбе с забытыми тропическими болезнями на 2021–2030 гг. («дорожная карта») определены глобальные цели и основные этапы в отношении борьбы с 20 бол...
The Global Antibiotic Resistance Partnership (GARP)-Mozambique team, in partnership with the Center for Disease Dynamics, Economics & Policy (CDDEP), has produced this report as part of a solid com-mitment to develop actionable policy proposals to tackle antibiotic resistance and improve appropriate...
With the goal of ending viral hepatitis as a public health threat by 2030, the Regional Action Plan will provide an actionable framework for implementing evidence-based interventions at scale. It will be informed through strategic monitoring of the response, that must be equitable and sustainable an...
The aim of the framework is to provide guidance to Member States and partners on region-specific priority actions towards the goals, targets and milestones of the GTS. The central pillar of the framework is the adoption of programme phasing and transitioning, aimed at facilitating a tailored approac...
The extensive use of antimicrobials in human and veterinary medicine in recent years has accelerated the emergence and spread of resistant microorganisms. This situation has been worsened by the lack of investment in developing new effective antibiotics. The severity of the consequences is clear to ...
The WHO country office for Ghana, began the year 2019 with a 4-day staff retreat at the Busua Beach Resort in the Western Region from 04 to 08 March 2019. The theme for the retreat was ‘Impacting the Health and Lives of the people of Ghana through the Triple Billion Goal”. The staff outlined pri...
orientations provisoires, première publication : 8 janvier 2021, mise à jour : 15 juin 2021, mise à jour : 19 novembre 2021, mise à jour : 21 janvier 2022
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...
